Correlation Between ANT and Memphis Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both ANT and Memphis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANT and Memphis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ANT and Memphis Pharmaceuticals, you can compare the effects of market volatilities on ANT and Memphis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANT with a short position of Memphis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANT and Memphis Pharmaceuticals.

Diversification Opportunities for ANT and Memphis Pharmaceuticals

-0.4

Correlation Coefficient

ANT  Memphis Pharmaceuticals

Very good diversification

The 3 months correlation between ANT and Memphis is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding ANT and Memphis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Memphis Pharmaceuticals and ANT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANT are associated (or correlated) with Memphis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Memphis Pharmaceuticals has no effect on the direction of ANT i.e., ANT and Memphis Pharmaceuticals go up and down completely randomly.

Pair Corralation between ANT and Memphis Pharmaceuticals

Assuming the 90 days trading horizon ANT is expected to generate 11.67 times more return on investment than Memphis Pharmaceuticals. However, ANT is 11.67 times more volatile than Memphis Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Memphis Pharmaceuticals is currently generating about 0.04 per unit of risk. If you would invest  933.00  in ANT on October 11, 2024 and sell it today you would lose (786.00) from holding ANT or give up 84.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	73.78%
Values	Daily Returns

ANT  vs.  Memphis Pharmaceuticals

ANT

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in ANT are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, ANT exhibited solid returns over the last few months and may actually be approaching a breakup point.

Memphis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Memphis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with ANT and Memphis Pharmaceuticals

The main advantage of trading using opposite ANT and Memphis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANT position performs unexpectedly, Memphis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Memphis Pharmaceuticals will offset losses from the drop in Memphis Pharmaceuticals' long position.

The idea behind ANT and Memphis Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.